News

Pharmabiz4h
MedTech zone innovative programme selected for BRICS+ Global Initiative
MedTech zone innovative programme selected for BRICS+ Global Initiative: Our Bureau, Mumbai Thursday, July 10, 2025, 14:20 ...
Pharmabiz6h
Cochlear introduces US FDA approved Cochlear Nucleus Nexa System, world’s first and only, smart cochlear implant system
Lone Tree, Colorado Thursday, July 10, 2025, 13:00 Hrs [IST] ...
Pharmabiz1h
Verified Clinical Trials begins ops in Japan in partnership with MRJ & JACIC to prevent duplicate and professional subjects in clinical trials
Verified Clinical Trials begins ops in Japan in partnership with MRJ & JACIC to prevent duplicate and professional subjects in clinical trials: Tokyo Thursday, July 10, 2025, 18:0 ...
Pharmabiz2h
Swissmedic approves Norgine’s Ifinwil for children diagnosed with high-risk neuroblastoma
Swissmedic approves Norgine’s Ifinwil for children diagnosed with high-risk neuroblastoma: Uxbridge, UK Thursday, July 10, 2025, 17:00 Hrs [IST] Norgine, a leading European spec ...
Pharmabiz3h
IA brings domain expertise, and compliance skills at its Medical Writing Conference on July 11 & 12
Our Bureau, Bengaluru Thursday, July 10, 2025, 15:45 Hrs [IST] ...
Pharmabiz2h
Cerapedics treats first US patient with PearlMatrix P-15 peptide enhanced bone graft following US FDA approval
Westminster, Colorado Thursday, July 10, 2025, 16:00 Hrs [IST] ...
Pharmabiz3h
Solid Biosciences gets US FDA IND & Health Canada CTA approvals for SGT-501 to treat catecholaminergic polymorphic ventricular tachycardia
Charlestown, Massachusetts Thursday, July 10, 2025, 15:30 Hrs [IST] ...
Pharmabiz4h
ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025
ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025: London, UK Thursday, July 10, 2025, 15:00 ...
Pharmabiz5h
MapLight Therapeutics initiates phase 2 ZEPHYR study of M1/M4 muscarinic agonist ML-007C-MA to treat schizophrenia
MapLight Therapeutics initiates phase 2 ZEPHYR study of M1/M4 muscarinic agonist ML-007C-MA to treat schizophrenia: Redwood City Thursday, July 10, 2025, 13:30 Hrs [IST] MapLight ...
Pharmabiz5h
US FDA approves updated label for Eli Lilly's Kisunla with new dosing in early symptomatic Alzheimer's disease
US FDA approves updated label for Eli Lilly's Kisunla with new dosing in early symptomatic Alzheimer's disease: Indianapolis Thursday, July 10, 2025, 14:00 Hrs [IST] Eli Lilly and ...
Pharmabiz7h
Maharashtra government expands free dialysis network with new centre at SDH Dharni, Amravati
Maharashtra government expands free dialysis network with new centre at SDH Dharni, Amravati: Our Bureau, Mumbai Thursday, July 10, 2025, 11:30 Hrs [IST] The Government of Maharas ...
Pharmabiz7h
Dr Varun Venkataramani, Heidelberg University Hospital, Germany, receives Eppendorf Award for Young European Investigators 2025
Dr Varun Venkataramani, Heidelberg University Hospital, Germany, receives Eppendorf Award for Young European Investigators 2025: Hamburg Thursday, July 10, 2025, 12:00 Hrs [IST] T ...